clindamycin has been researched along with Hidradenitis Suppurativa in 60 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (3.33) | 18.2507 |
| 2000's | 3 (5.00) | 29.6817 |
| 2010's | 33 (55.00) | 24.3611 |
| 2020's | 22 (36.67) | 2.80 |
| Authors | Studies |
|---|---|
| Grabbe, S; Kirschner, U; Matusiak, Ł; Nikolakis, G; Ruckes, C; Schultheis, M; Staubach, P; Szepietowski, JC; von Stebut, E | 2 |
| Buerger, C; Diehl, S; Haferland, I; Ickelsheimer, T; Kaufmann, R; Koenig, A; Pinter, A; Schiffmann, S; Wacker, MG; Wallenwein, CM | 1 |
| Barak Levitt, J; Barmatz, S; Dalal, A; Fisch-Gilad, S; Hackett, A; Hodak, E; Kremer, N; Levi, A; Pavlovsky, L; Sherman, S; Taieb, Y; Yahav, D | 1 |
| Drekonja, D; Goldfarb, N; Greenlund, LK; Herzog, C | 1 |
| Brisigotti, V; D'Agostino, GM; Giacchetti, A; Molinelli, E; Offidani, A; Rizzetto, G; Sapigni, C; Simonetti, O | 1 |
| Egeberg, A; Frew, JW; Ingram, JR; Maul, JT; Nielsen, ML; Ring, HC; Thomsen, SF; Thorsen, J; Thyssen, JP; Wu, JJ; Yao, Y | 1 |
| Adwa, U; Mose, AP; Svedman, C | 1 |
| Aarts, P; Ardon, CB; Prens, EP; Reeves, JL; van der Zee, HH | 1 |
| Brisigotti, V; Campanati, A; Molinelli, E; Neri, I; Offidani, A; Patrizi, A; Raone, B; Sechi, A | 1 |
| Albrecht, J; Bigby, M | 1 |
| Bragg, DA; Litzner, B; Wipperman, J | 1 |
| Abdel-Wahab, H; Abdelghani, R; Agut-Busquet, E; Becherel, PA; Beksaç, B; Benhadou, F; Bettoli, V; Bouazzi, D; Calamo, G; Del Marmol, V; Delage-Toriel, M; Dolenc-Voljc, M; Doss, N; El-Domyati, M; Emtestam, L; Fatani, M; Glowaczewska, A; Guillem, P; Gürer, MA; Hlela, C; Jemec, GBE; Kappe, NN; Kottb, HR; Lam, TTH; Lapins, J; Matusiak, L; Moftah, N; Nassif, A; Pascual, JC; Prens, EP; Riis, PT; Romaní, J; Saunte, DM; Sigsgaard, V; Szepietowski, JC; Theiler, M; van den Worm, L; van der Zee, HH; Vanlaerhoven, AMJD; Villani, AP; Weibel, L | 1 |
| Brisigotti, V; Campanati, A; Cota, C; D'Agostino, GM; Giacchetti, A; Molinelli, E; Offidani, A; Sapigni, C; Simonetti, O | 1 |
| Bianchi, L; Brisigotti, V; Caposiena Caro, RD; Molinelli, E; Offidani, A | 1 |
| Jørgensen, AR; Ring, HC; Thomsen, SF; Yao, Y | 1 |
| Alonso, A; Anjos, JLV; Cunha-Filho, M; Gelfuso, GM; Gratieri, T; Pereira, MN; Pires, FQ; Tolentino, S | 1 |
| Benhadou, F; Cuenca-Barrales, C; Daoud, M; Daxhelet, M; Efthymiou, O; Giamarellos-Bourboulis, EJ; Guillem, P; Jemec, GBE; Katoulis, AC; Koenig, A; Lazaridou, E; Marzano, AV; Matusiak, Ł; Molina-Leyva, A; Moltrasio, C; Pinter, A; Potenza, C; Romaní, J; Saunte, DM; Skroza, N; Stergianou, D; Szepietowski, J; Trigoni, A; Tzellos, T; van der Zee, HH; van Straalen, KR; Vilarrasa, E | 1 |
| Bettoli, V; Corazza, M; Forconi, R; Odorici, G; Toni, G | 1 |
| Becker, M; Hauptmann, M; Kristandt, A; Nikolakis, G; Zouboulis, CC | 1 |
| Charrow, AP; Kwak, R; Lopez, CG; Nambudiri, VE; Noe, MH | 1 |
| Boibieux, A; Delaunay, J; Guillem, P; Jullien, D; Tristan, A; Villani, AP | 1 |
| Duarte, R; Macedo, R; Mendes-Bastos, P | 1 |
| Fernández-Palacios, J; García-Duque, O; Pacheco, YD | 1 |
| Ardon, CB; Ejaz, RN; Fuursted, K; Jemec, GBE; Jenssen, H; Prens, EP; Shailes, J | 1 |
| Bessaleli, E; Scheinfeld, N | 1 |
| Annunziata, MC; Donnarumma, M; Fabbrocini, G; Marasca, C; Palma, M; Vastarella, M | 1 |
| Albrecht, J; Baine, PA; Bigby, M; Jemec, GB; Ladizinski, B | 1 |
| Ferrucci, S; Guanziroli, E; Nazzaro, G; Veraldi, S | 1 |
| Annunziata, MC; Bettoli, V; Fabbrocini, G; Luciano, MA; Marasca, C; Masarà, A | 1 |
| Albrecht, J; Barbaric, J; Nast, A | 2 |
| Bianchi, L; Botti, E; Cannizzaro, MV; Caposiena Caro, RD; Di Matteo, E; Di Raimondo, C; Gaziano, R | 1 |
| Di Cesare, A; Novelli, A; Pescitelli, L; Pimpinelli, N; Prignano, F; Ricceri, F; Rosi, E | 1 |
| Bianchi, L; Caposiena Caro, RD | 1 |
| Azaña, JM; Cañueto, J; Díaz-Ley, B; González-López, MA; Lázaro, M; Leiva-Salinas, M; Martorell, A; Molina-Leyva, A; Navarro-Triviño, FJ; Pascual, JC; Romaní, J; Sánchez-Payá, J; Schneller-Pavelescu, L; Segura Palacios, JM; Vázquez-Osorio, I; Vergara-de Caso, E; Vilarrasa, E | 2 |
| Annunziata, MC; Fabbrocini, G; Fattore, D; Marasca, C; Masarà, A | 1 |
| Jemec, GB; Yazdanyar, S | 1 |
| Hambly, R; Kirby, B | 1 |
| Annunziata, MC; Fabbrocini, G; Marasca, C; Marasca, D; Villani, A; Volpe, S | 1 |
| Alfageme-Roldán, F; Fernández-Canga, P; Roustán-Gullón, G; Turrión-Merino, L | 1 |
| Bettoli, V; Borghi, A; Minghetti, S; Ricci, M; Toni, G; Virgili, A; Zauli, S | 1 |
| Jemec, GB; Mikkelsen, PR | 1 |
| Bilgili, ME; Ercan, E; Karabudak Abuaf, O; Senol, L; Yildiz, H | 1 |
| Alavi, A; Kirsner, RS | 1 |
| Emtestam, L; Ring, HC | 1 |
| Bettoli, V; Join-Lambert, O; Nassif, A | 1 |
| Burton, T; Chua, SL; Desai, N; Garner, SE; Hood, K; Ingram, JR; Kai, AC; Kerdel, F; Ormerod, AD; Piguet, V; Woo, PN | 1 |
| Bettoli, V; Virgili, A; Zauli, S | 1 |
| Scheinfeld, N | 1 |
| Antoniou, C; Dessinioti, C; Stratigos, A; Tzanetakou, V; Zisimou, C | 1 |
| Bastuji-Garin, S; Canoui-Poitrine, F; Faye, O; Gabison, G; Gener, G; Poli, F; Pouget, F; Revuz, JE; Viallette, C; Wolkenstein, P | 1 |
| Boer, J; Jemec, GB; Prens, EP; van der Zee, HH | 1 |
| Poli, F; Revuz, J; Wolkenstein, P | 1 |
| Kirby, B; Wall, D | 1 |
| Hamzavi, I; Lim, HW; Rambhatla, PV | 1 |
| Griffiths, CE; Mendonça, CO | 1 |
| Jemec, GB; Wendelboe, P | 1 |
| Brown, TJ; Orengo, IF; Rosen, T | 1 |
10 review(s) available for clindamycin and Hidradenitis Suppurativa
| Article | Year |
|---|---|
Penile and scrotal lymphedema associated with hidradenitis suppurativa: Case report and review of surgical options.
Topics: Adult; Clindamycin; Cutaneous Fistula; Doxycycline; Genital Diseases, Male; Hidradenitis Suppurativa; Humans; Lymphedema; Magnetic Resonance Imaging; Male; Penile Diseases; Scrotum; Skin Transplantation | 2018 |
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
Topics: Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clindamycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Drug Interactions; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Hidradenitis Suppurativa; Humans; Meta-Analysis as Topic; Nephritis, Interstitial; Rifampin; Risk Assessment; Systematic Reviews as Topic; Time Factors | 2019 |
Hidradenitis suppurativa in children and adolescents: a review of treatment options.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Child; Clindamycin; Hidradenitis Suppurativa; Humans; Immunosuppressive Agents; Retinoids | 2014 |
Local wound care and topical management of hidradenitis suppurativa.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents, Local; Clindamycin; Combined Modality Therapy; Female; Hidradenitis Suppurativa; Humans; Keratolytic Agents; Male; Prognosis; Resorcinols; Retinoids; Severity of Illness Index; Skin Care; Treatment Outcome; Wound Healing; Young Adult | 2015 |
The Microbiology of Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; Biofilms; Clindamycin; Corynebacterium Infections; Hidradenitis Suppurativa; Humans; Rifampin; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tetracycline | 2016 |
Antibiotic Treatment of Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Clindamycin; Drug Therapy, Combination; Ertapenem; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Imipenem; Maintenance Chemotherapy; Metronidazole; Moxifloxacin; Remission Induction; Rifampin | 2016 |
Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality.
Topics: Adalimumab; Administration, Oral; Adult; Androgen Antagonists; Anti-Bacterial Agents; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Etanercept; Ethinyl Estradiol; Gentamicins; Hidradenitis Suppurativa; Humans; Infliximab; Norgestrel; Quality of Life; Treatment Outcome; Wound Closure Techniques | 2016 |
Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Biofilms; Clindamycin; Corynebacterium Infections; Drug Therapy, Combination; Granuloma; Hidradenitis Suppurativa; Humans; Immunologic Factors; Neutrophils; Rifampin; Staphylococcal Infections; Streptococcal Infections | 2016 |
A systematic review of treatments for hidradenitis suppurativa.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Biological Products; Clindamycin; Dermatologic Agents; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Infliximab; Lasers, Solid-State; Rifampin | 2012 |
Hidradenitis suppurativa.
Topics: Adult; Anti-Bacterial Agents; Apocrine Glands; Clindamycin; Diagnosis, Differential; Epithelium; Female; Furunculosis; Hair Follicle; Hidradenitis Suppurativa; Humans; Isotretinoin; Keratolytic Agents; Male; Prevalence; Prognosis; Recurrence; Sex Factors | 1998 |
6 trial(s) available for clindamycin and Hidradenitis Suppurativa
| Article | Year |
|---|---|
LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
Topics: Anti-Bacterial Agents; Chronic Disease; Clindamycin; Hidradenitis Suppurativa; Humans; Quality of Life; Severity of Illness Index; Treatment Outcome | 2022 |
LAight® Therapy Is an Effective Treatment Option to Maintain Long-Term Remission of Hurley I and II Hidradenitis Suppurativa: Results from Period B of RELIEVE, a Multicenter Randomized, Controlled Trial.
Topics: Anti-Bacterial Agents; Clindamycin; Hidradenitis Suppurativa; Humans; Severity of Illness Index; Treatment Outcome | 2022 |
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Clindamycin; Hidradenitis Suppurativa; Humans; Pain; Pilot Projects; Severity of Illness Index; Treatment Outcome | 2023 |
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study
Topics: Adalimumab; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clindamycin; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Injections, Subcutaneous; Male; Quality of Life; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Young Adult | 2019 |
A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa.
Topics: Adult; Anti-Bacterial Agents; C-Reactive Protein; Clindamycin; Combined Modality Therapy; Erythrocyte Indices; Female; Hidradenitis Suppurativa; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Pain Measurement; Prospective Studies; Quality of Life; Rifampin; Severity of Illness Index; Young Adult | 2016 |
Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-Bacterial Agents; Clindamycin; Double-Blind Method; Female; Hidradenitis Suppurativa; Humans; Male; Tetracycline; Treatment Outcome | 1998 |
44 other study(ies) available for clindamycin and Hidradenitis Suppurativa
| Article | Year |
|---|---|
Mechanism of anti-inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativa.
Topics: Anti-Inflammatory Agents; Clindamycin; Hidradenitis Suppurativa; Humans; Rifampin; Toll-Like Receptor 2 | 2022 |
The Bacteriology of Skin Lesions in Patients with Hidradenitis Suppurativa Is Associated with Previous Antibiotic Treatment in the Community Setting: A Referral Center Experience.
Topics: Adult; Anti-Bacterial Agents; Bacteriology; Ciprofloxacin; Clindamycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hidradenitis Suppurativa; Humans; Referral and Consultation; Rifampin; Sulfamethoxazole; Trimethoprim | 2022 |
Response to the article by Kwak et al entitled "No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin".
Topics: Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Hidradenitis Suppurativa; Humans; Incidence | 2022 |
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
Topics: Anti-Bacterial Agents; Clindamycin; Hidradenitis Suppurativa; Humans; Resorcinols; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2022 |
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Topics: Acitretin; Anti-Bacterial Agents; Biological Factors; Biological Products; Clindamycin; Dapsone; Dicloxacillin; Drug Utilization; Hidradenitis Suppurativa; Humans; Isotretinoin; Rifampin; Tetracyclines | 2022 |
Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; Clindamycin; Dermatitis, Allergic Contact; Hidradenitis Suppurativa; Humans | 2022 |
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Clindamycin; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Hidradenitis Suppurativa; Humans; Hyperandrogenism; Hyperinsulinism; Practice Guidelines as Topic; Puberty, Precocious | 2019 |
Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, a
Topics: Anti-Bacterial Agents; Canada; Clindamycin; Hidradenitis Suppurativa; Humans; North American People; Rifampin; United States | 2023 |
Hidradenitis Suppurativa: Rapid Evidence Review.
Topics: Adalimumab; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Curriculum; Drug Therapy; Education, Medical, Continuing; Female; Hidradenitis Suppurativa; Humans; Male; Practice Guidelines as Topic; Risk Factors; Tetracyclines; Young Adult | 2019 |
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Anti-Bacterial Agents; Body Mass Index; Child; Clindamycin; Comorbidity; Cross-Sectional Studies; Dermatologic Surgical Procedures; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Hirsutism; Humans; Male; Obesity; Pilonidal Sinus; Resorcinols; Rifampin; Risk Factors; Severity of Illness Index; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2020 |
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Hidradenitis Suppurativa; Humans; Resorcinols | 2020 |
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clindamycin; Disease-Free Survival; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Lymecycline; Male; Middle Aged; Pain Measurement; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Ultrasonography; Young Adult | 2021 |
Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Prospective Studies; Rifampin | 2021 |
Nanostructured lipid carriers for hair follicle-targeted delivery of clindamycin and rifampicin to hidradenitis suppurativa treatment.
Topics: Clindamycin; Drug Carriers; Hair Follicle; Hidradenitis Suppurativa; Humans; Lipids; Rifampin; Skin Absorption | 2021 |
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
Topics: Adult; Clindamycin; Cohort Studies; Drug Combinations; Europe; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Prospective Studies; Rifampin; Tetracyclines; Treatment Outcome | 2021 |
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa in patients of paediatric age: a pilot prospective study.
Topics: Anti-Bacterial Agents; Child; Clindamycin; Hidradenitis Suppurativa; Humans; Prospective Studies; Rifampin | 2021 |
Efficacy of short-term intravenous clindamycin prior to oral clindamycin-rifampicin treatment in hidradenitis suppurativa: a retrospective case series.
Topics: Anti-Bacterial Agents; Clindamycin; Hidradenitis Suppurativa; Humans; Retrospective Studies; Rifampin | 2021 |
No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Hidradenitis Suppurativa; Humans; Incidence | 2022 |
Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Ofloxacin; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2018 |
Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clindamycin; Contraindications, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fluoroquinolones; Hidradenitis Suppurativa; Humans; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant | 2017 |
Biofilm production and antibiotic susceptibility of Staphylococcus epidermidis strains from Hidradenitis Suppurativa lesions.
Topics: Anti-Bacterial Agents; Biofilms; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Hidradenitis Suppurativa; Humans; Microbial Sensitivity Tests; Rifampin; Staphylococcus epidermidis; Tetracycline | 2019 |
Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Female; Hidradenitis Suppurativa; Humans; Middle Aged; Rifampin | 2018 |
An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Clindamycin; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Energy Intake; Folic Acid; Glucose Intolerance; Hidradenitis Suppurativa; Humans; Inositol; Insulin Resistance; Liposomes; Magnesium; Metabolic Syndrome; Prevalence; Rifampin; Severity of Illness Index | 2020 |
Allergic contact dermatitis caused by clindamycin.
Topics: Anti-Bacterial Agents; Clindamycin; Dermatitis, Allergic Contact; Female; Hidradenitis Suppurativa; Humans; Middle Aged | 2019 |
Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Rifampin | 2019 |
Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin-rifampicin combination for hidradenitis suppurativa?
Topics: Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Rifampin | 2019 |
Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Body Mass Index; Clindamycin; Disease-Free Survival; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Pain; Quality of Life; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Ultrasonography; Young Adult | 2019 |
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Pain; Pain Measurement; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2019 |
Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa?
Topics: Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Rifampin | 2019 |
Clindamycin alone may be enough. Is it time to abandon rifampicin for hidradenitis suppurativa? Reply from the authors.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Rifampin | 2019 |
Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
Topics: Administration, Oral; Adult; Age Factors; Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Male; Medication Adherence; Middle Aged; Retrospective Studies; Rifampin; Smoking | 2019 |
Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes".
Topics: Anti-Bacterial Agents; Clindamycin; Hidradenitis Suppurativa; Humans; Prevalence; Rifampin | 2023 |
Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'".
Topics: Anti-Bacterial Agents; Clindamycin; Hidradenitis Suppurativa; Humans; Prevalence; Rifampin | 2023 |
KITTEN following CAT on the long-term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives.
Topics: Anti-Bacterial Agents; Clindamycin; Contraceptives, Oral; Female; Hidradenitis Suppurativa; Humans; Rifampin | 2019 |
Prolonged clindamycin and rifampicin for hidradenitis suppurativa: resist to prevent resistance.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Rifampin | 2019 |
Sonographic features and successful treatment of stump hidradenitis suppurativa.
Topics: Adult; Amputation Stumps; Anti-Bacterial Agents; Artificial Limbs; Clindamycin; Doxycycline; Female; Hidradenitis Suppurativa; Humans; Ultrasonography | 2019 |
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients.
Topics: Administration, Oral; Adolescent; Adult; Clindamycin; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Prospective Studies; Rifampin; Young Adult | 2014 |
Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Rifampin; Treatment Outcome; Young Adult | 2016 |
Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Female; Follow-Up Studies; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Prospective Studies; Rifampin; Young Adult | 2016 |
Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
Topics: Administration, Oral; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hidradenitis Suppurativa; Humans; Male; Patient Satisfaction; Quality of Life; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome | 2009 |
The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
Topics: Administration, Oral; Adult; Clindamycin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Patient Satisfaction; Quality of Life; Retrospective Studies; Rifampin; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
Back and face involvement in hidradenitis suppurativa.
Topics: Acne Vulgaris; Adult; Back; Cicatrix; Clindamycin; Dermatologic Agents; Epidermal Cyst; Face; Female; Hidradenitis Suppurativa; Humans; Isotretinoin; Male; Middle Aged; Pilonidal Sinus; Rifampin; Skin Ulcer; Treatment Outcome; Young Adult | 2010 |
Rifampicin and clindamycin for hidradenitis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Clindamycin; Drug Therapy, Combination; Hidradenitis Suppurativa; Humans; Rifampin | 2011 |
Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome | 2006 |